Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, α1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate

Leukemia Research

Volumn 22, Issue 6, 1998, Pages 537-547

  Trayner, Ian D ^a   Bustorff, Theresa ^a   Etches, Ann E ^b   Mufti, Ghulam J ^b   Foss, Yvonne ^a   Farzaneh, Farzin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antigen expression; HL60 cells; Leukemic myeloid cell differentiation

Indexed keywords

CALCITRIOL; CD15 ANTIGEN; CD16 ANTIGEN; CD31 ANTIGEN; CD32 ANTIGEN; CD33 ANTIGEN; CD63 ANTIGEN; CD68 ANTIGEN; CD71 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; DIFFERENTIATION ANTIGEN; DIMETHYL SULFOXIDE; MICROSOMAL AMINOPEPTIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; GRANULOCYTE; HLA TYPING; HUMAN; HUMAN CELL; LEUKOCYTE; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

ANTIGENS, CD; CALCITRIOL; CELL DIFFERENTIATION; DIMETHYL SULFOXIDE; HL-60 CELLS; HUMANS; TETRADECANOYLPHORBOL ACETATE; TRETINOIN;

EID: 0032102536     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00041-1     Document Type: Article

References (42)

1. Collins S.J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 70:1987;1233.
2. Collins S.J., Gallo R.C., Gallagher R.E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 270:1977;347.
3. Dalton W.T., Ahearn M.J., McCredie K.B., Freireich E.J., Stass S.A., Trujillo J.M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood. 71:1988;242.
4. Gallagher R.E., Collins S.J., Trujillo J., McCredie K., Ahearn M., Tsai S., Metzgar R., Aulakh G., Ting R., Ruscetti F.W., Gallo R.C. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 54:1979;713.
5. Kontani K., Nishina H., Ohoka Y., Takahashi K., Katada T. NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells - identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. J Biol Chem. 268:1993;16895.
6. Shinagawa T., Nunoi H., Nonoyama S., Kanegasaki S. Induction of CD40 in promyelocytic HL60 cells cultured with retinoic acid and/or various cytokines. J Biochem. 118:1995;534.
7. 3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun. 117:1983;86.
8. Razak K., Allen P.D., Kelsey S.M., Gutteridge C.N., Newland A.C. Modulation of CD13 expression during retinoic acid-induced differentiation of HL60 cells. Leukemia Res. 18:1994;629.
9. Barker K.A., Newburger P.E. Relationship between the cell cycle and the expression of c-myc and transferrin receptor genes during induced myeloid differentiation. Exp Cell Res. 186:1990;1.
10. Trowbridge I.S., Lopez F. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc Natl Acad Sci USA. 79:1982;1175.
11. Ho P.T.C., Ishiguro K., Sartorelli A.C. Regulation of transferrin receptor in myeloid and monocytic differentiation of HL-60 leukemia cells. Cancer Res. 49:1989;1989.
12. Hsu H.C., Yang K., Kharbanda S., Clinton S., Datta R., Stone R.M. All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cells. Leukemia Res. 7:1993;458.
13. Todd RF. Myeloid antigens: section report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. Oxford: Oxford University Press, 1995:739.
14. Skubitz KM, Micklem K, van der Schoot CE. CD66 and CD67 cluster workshop report. In: Schlossman SF, Boumseil L, Gilks WR, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:889.
15. Trayner I.D., Rayner A.P., Freeman G.E., Farzaneh F. Quantitative multiwell myeloid differentiation assay using dichlorodihydrofluorescein diacetate (H2DCF-DA) or dihydrorhodamine-123 (H(2)R123). J Immunol Methods. 186:1995;275.
16. Poon RYM, Johnson R, Stanton T, Fernandez-Repollet E, Schwartz A. Calibration of fluorescent intensity microbead standards and assignment of effective fluorescein/protein ratios to the fluorescein isothiocyanate (FlTC)-conjugated secondary antigodies used in the Fifth Workshop. In: Schlossman SF, Boumsell L, Gilks WR, Harlan JM, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:13.
17. Shaw S, Luce GG, Gilks WR, Anderson K, Ault K, Bochner BS, Boumsell L, Denning SM, Engleman EG, Fleisher T, Freedman AS, Fox DA, Gailit J, Gutierrez-Ramos JC, Hurtubise PE, Landsdorp P, Lotze MT, Marwhorter S, Marti G, Matsuo Y, Minowada J, Michelson A, Picker L, Ritz J, Roos E, van der Schoot CE, Springer TA, Tedder TF, Telen MJ, Thompson JS, Valent P. Leukocyte differentiation antigen database. In: Schlossman SF, Boumsell L, Gilks WR, Harlan JM, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. Whitle Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:13.
18. Collins S.J., Ruscetti F.W., Gallagher R.E., Gallo R.C. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med. 149:1979;969.
19. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA. 77:1980;2936.
20. 3 inhibits proliferation of human promyelocytic leukemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leukemia Res. 7:1983;51.
21. Rovera G., Santoli D., Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol ester. Proc Natl Acad Sci USA. 76:1979;2779.
22. Todd R.F., Griffin J.D., Ritz J., Nadler L.M., Abrams T., Schlossman S.F. Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte conditioned medium or phorbol ester. Leukemia Res. 5:1981;491.
23. Fontana J.A., Colbert D.A., Deisseroth A.B. Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line. Proc Natl Acad Sci USA. 78:1981;3863.
24. Ball ED. CD15 cluster workshop report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. Oxford: Oxford University Press, 1995:790.
25. X) antigen: expression on non-haemopoietic cell lines and modulation on retinoic acid-induced HL-60 cells. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:798.
26. Di Noto R., Schiavone E.M., Ferrara F., Manzo C., Lo Pardo C., Delvecchio L. All-trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells. Br J Haematol. 88:1994;274.
27. Koch AE, Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong T, Fu R, Lin SJ. Immunohistochemical characterization of myeloid antigens in arthritic and normal synovial tissues. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:1010.
28. Mielke V. Immunohistology on human skin. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:199.
29. Oppermann M. CD88 (C5a receptor) cluster report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:953.
30. Mai I, Pickl WF, Stockl J, Majdic O, Mellors A, De Smet W, Xu H, Peters JH, Knapp W. CD93 (group 11) cluster workshop report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:986.
31. Knapp W, Majdic O, Blanchard D, Chia W, Feizi T, Gyimesi E, Hirabayashi Y, Howard CJ, Kniep B, Thompson JS, Wiels J, Wijdenes J. CDw65 cluster report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:876.
32. Madjic O, Gadd SJ, Mai I, Stockl J, Pickl WF, Knapp W. Cellular distribution and biochemical aspects of the CDw65 cluster. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. Oxford: Oxford University Press, 1995:882.
33. Bordessoule D., Jones M., Gatter K.C., Mason D.Y. Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. Br J Haematol. 83:1993;370.
34. Pulford K, Murray N, Mason DY. The immunocytochemical distribution of the CD16, CDw32 and CD64 antigens. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. Oxford: Oxford University Press, 1995:817.
35. Cordell JL, Falini B, Flenghi L, Jones DB, Pileri S, Radzun HJ, Wilkins BS. CD68 cluster workshop report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. Oxford: Oxford University Press, 1995:925.
36. Faccheti F, Maracolo D, Battocchio S, Cominotti A, Tironi A. The reactivity of the myeloid blind panel mAb with monocyte-derived and dendritic cells in human lymph nodes. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. Oxford: Oxford University Press, 1995:1007.
37. Budde P, Bewarder N, Weinrich V, Sondermann P, Kilian A, Frey J. Specificity of CD16 mAb for FcRIIIB expressed in transfected mouse B cells and BHK-2 1 cells. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. Oxford: Oxford University Press, 1995:806.
38. Tamm A, Zielinska-Skowronek M, Van Aaken K, Schmidt RE. Phenotypic and functional characteristics of CD16 mAb. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:808.
39. De Haas M, Kleijer M, Roos D, Von dem Borne AEGK. Characterization of the mAb of the CD16 cluster and six newly generated CD16 mAb. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:811.
40. Morelli A, Larregina A, Barboza M, Achino B, Kolkowski E, Fainboim L. Reaction patterns of workshop myeloid blind panel mAb with solid tissues, peripheral blood leukocytes, myeloid cell lines, and dendritic cells. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:1014.
41. Todd RF, Barnathan ES, Bohuslav J, Chapman HA, Cuhan RL, Felez J, Howell A, Johnson GJ, Knapp W, Kramer M, Miles LA, Nykjaer A, Ralfkiaer E, Schuren E. CD87 cluster workshop report. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF, editors. Leukocyte Typing V. White Cell Differentiation Antigens. Oxford: Oxford University Press, 1995:932.
42. Bunce C.M., Wallington L.A., Harrison P., Williams G.R., Brown G. Treatment of HL60 cells with various combinations of retinoids and 1-alpha,25-dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or failure to differentiate and apoptosis. Leukemia. 9:1995;410.